Monoclonal antibody
Type Whole antibody
Source Chimeric (mouse/human)
Target mesothelin
Clinical data
ATC code none
CAS Number 931402-35-6 N
ChemSpider none
Chemical and physical data
Formula C6394H9870N1694O2024S46
Molar mass 144.33 kg/mol (peptide)
 NYesY (what is this?)  (verify)

Amatuximab is a chimeric monoclonal antibody designed for the treatment of cancer.[1]

Amatuximab was developed by Morphotek, Inc.

Amatuximab is also known as Anti-mesothelin monoclonal antibody MORAb-009. Amatuximab is an anti-mesothelin monoclonal antibody MORAb-009 binds to mesothelin (a protein that is made by some cancer cells) and stops the cells from dividing, and also called MORAb-009.


This article is issued from Wikipedia - version of the 8/13/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.